NPM1 protein network highlighted with glowing light, symbolizing scientific discovery in cancer research.

Cracking Cancer's Code: How Understanding Protein Phosphorylation Could Revolutionize Radiotherapy

Author's portrait.
Beau Callahan in Health & Wellness December 2025 • 4 min read.

"New research illuminates how modifying NPM1 protein could make tumor cells more vulnerable to radiation, offering a beacon of hope in the fight against treatment resistance."


Despite remarkable progress in cancer therapy, treatment resistance and tumor recurrence remain formidable challenges. Cancer stands as the second leading cause of death in the Western world, with projections estimating over 20 million new cases by 2025, a significant increase from the 14.1 million reported in 2012 [1].

Radiotherapy, a cornerstone in cancer treatment, offers a non-invasive approach with less systemic toxicity compared to chemotherapy [2]. Approximately 40% of cancer patients achieve remission through radiotherapy, either alone or in combination with other therapies [3]. However, its curative potential is often limited by tumor cells developing resistance mechanisms that allow them to survive and repopulate. Overcoming these resistance mechanisms is crucial to improving cancer treatment outcomes [4].

The fate of a cell post-irradiation hinges on the DNA damage response, which determines whether the cell will undergo programmed cell death or repair the damage. Post-translational modifications, especially phosphorylation and dephosphorylation, play a vital role in coordinating this response at various levels [5]. Understanding how these modifications alter the phosphoproteome in response to irradiation could unlock new therapeutic strategies.

Unlocking Radiosensitivity: The Role of NPM1

NPM1 protein network highlighted with glowing light, symbolizing scientific discovery in cancer research.

A recent study published in "Translational Oncology" sheds light on the role of nucleophosmin (NPM1), a multifunctional protein, in the radiation response of tumor cells. The researchers used phosphoproteomic profiling to identify proteins regulated upon irradiation, highlighting NPM1 as a key player in tumor cell survival.

NPM1 is involved in a myriad of cellular processes, including ribosome biogenesis, genomic stability, DNA repair, and response to various stress stimuli [15-28]. Its dynamic localization within the cell—shuttling between the nucleoli, nucleoplasm, and cytoplasm—is crucial for its diverse functions [29-31]. Given its involvement in tumorigenesis and its regulation by phosphorylation and dephosphorylation, NPM1 presents a promising target for radiosensitization [32-47].

  • Experiment Highlights: Researchers irradiated tumor cells and analyzed changes in protein phosphorylation before and after exposure.
  • Key Finding: Knockdown of NPM1 significantly reduced tumor cell survival post-irradiation.
  • Mechanism: NPM1 is dephosphorylated stepwise within one hour after irradiation at threonine-199 and threonine-234/237, two major phosphorylation sites.
  • Implication: This dephosphorylation is part of the immediate response to irradiation and is crucial for tumor cell survival.
The team found that NPM1 is dephosphorylated at threonine-199 and threonine-234/237 within one hour of irradiation. Further investigation revealed that this dephosphorylation isn't due to a fast cell cycle arrest. Instead, NPM1 displays a heterogeneous intracellular distribution, moving between the nucleoli, nucleoplasm, and cytoplasm. These findings suggest that dephosphorylation of NPM1 at these key sites is part of the immediate response to irradiation and is important for tumor cell survival.

The Future of Radiotherapy: Targeting NPM1

These insights suggest that NPM1 could be a valuable pharmaceutical target to radiosensitize tumor cells, potentially improving radiotherapy outcomes by disrupting the pathways that help cancer cells evade cell death after irradiation. Further research into the cooperative activity of NPM1 phosphorylation sites could provide a more detailed understanding of its role in the early irradiation response, potentially leading to new strategies to combat radiation resistance.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

1

What is radiotherapy, and why is it important in cancer treatment?

Radiotherapy is a cancer treatment that uses radiation to kill cancer cells. It's important because it is a non-invasive method with less systemic toxicity compared to chemotherapy. Radiotherapy's effectiveness, however, is often limited by tumor cells developing resistance mechanisms, which allows them to survive radiation and continue to proliferate. Overcoming these resistance mechanisms is a key challenge in improving cancer treatment outcomes. Scientists are trying to understand the DNA damage response, especially phosphorylation and dephosphorylation to develop new therapeutic strategies.

2

What is NPM1, and why is it important in the context of cancer research?

NPM1, or nucleophosmin, is a multifunctional protein involved in various cellular processes, including ribosome biogenesis, genomic stability, DNA repair, and response to stress. It's significant because its dynamic movement within the cell between the nucleoli, nucleoplasm, and cytoplasm is crucial for its function. NPM1 is regulated by phosphorylation and dephosphorylation, making it a promising target for radiosensitization. By understanding how NPM1 functions, scientists hope to improve cancer treatment.

3

What are phosphorylation and dephosphorylation, and why are they important in understanding the cellular response to radiation?

Phosphorylation is a post-translational modification where a phosphate group is added to a protein. Dephosphorylation is the removal of that phosphate group. These processes are crucial because they control the DNA damage response determining whether a cell repairs itself or dies after radiation exposure. In the context of cancer treatment, understanding how phosphorylation and dephosphorylation affect proteins like NPM1 can reveal new strategies to make tumor cells more vulnerable to radiotherapy.

4

What is phosphoproteomic profiling, and how does it contribute to cancer research and treatment?

Phosphoproteomic profiling is a method used to analyze changes in protein phosphorylation. It is important because it helps researchers identify proteins that are regulated upon irradiation, like NPM1. This technique allows scientists to understand how tumor cells develop resistance to radiotherapy. It paves the way for developing treatments that can overcome this resistance and improve cancer outcomes.

5

What is the significance of NPM1 dephosphorylation at threonine-199 and threonine-234/237 after irradiation?

Dephosphorylation of NPM1 at threonine-199 and threonine-234/237 is an immediate response to irradiation. It is significant because it is crucial for tumor cell survival. Understanding why this dephosphorylation occurs and how it helps tumor cells survive could lead to new strategies to combat radiation resistance. Targeting these specific phosphorylation sites could disrupt the pathways that help cancer cells evade cell death after irradiation, making radiotherapy more effective.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.